Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion
Bristol Myers Squibb Co. said Sunday it will buy Mirati Therapeutics Inc. in a deal valued at up to $5.8 billion. The pharmaceutical giant announced it will pay…
Read more Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billion